Age: 0.75
Sex: M
Vaccine: COVID19-2
Symptoms: No adverse event, Wrong product administered
Clinical narrative: No adverse event; A patient who has received no previous Moderna vaccines did receive a 0.2mL dose of the Moderna Bivalent from the Pink cap vial./Due to staff confusion over which of the bivalent vaccine to use, pt was incorrectly given a "booster" or yellow label/pi; This spontaneous case was reported by an other health care professional and describes the occurrence of WRONG PRODUCT ADMINISTERED (A patient who has received no previous Moderna vaccines did receive a 0.2mL dose of the Moderna Bivalent from the Pink cap vial./Due to staff confusion over which of the bivalent vaccine to use, pt was incorrectly given a "booster" or yellow label/pi) and NO ADVERSE EVENT (No adverse event) in a 9-month-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 201L22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 18-May-2023, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .2 milliliter. On 18-May-2023, the patient experienced WRONG PRODUCT ADMINISTERED (A patient who has received no previous Moderna vaccines did receive a 0.2mL dose of the Moderna Bivalent from the Pink cap vial./Due to staff confusion over which of the bivalent vaccine to use, pt was incorrectly given a "booster" or yellow label/pi). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (A patient who has received no previous Moderna vaccines did receive a 0.2mL dose of the Moderna Bivalent from the Pink cap vial./Due to staff confusion over which of the bivalent vaccine to use, pt was incorrectly given a "booster" or yellow label/pi) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (A patient who has received no previous Moderna vaccines did receive a 0.2mL dose of the Moderna Bivalent from the Pink cap vial./Due to staff confusion over which of the bivalent vaccine to use, pt was incorrectly given a "booster" or yellow label/pi).    No concomitant medications were reported.  It was reported that the patient who has received no previous Moderna vaccines did receive a 0.2mL dose of the Moderna Bivalent from the Pink cap vial. No side effects were reported by parents. Due to staff confusion over which of the bivalent vaccine to use, patient was incorrectly given a "booster" or yellow label/pink top vial as a first dose. It was unknown if the patient experienced any additional symptoms/events.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 31-May-2023: Live Significant follow-up appended: Patient details updated, Event details updated, Suspect product details updated and Case narrative updated.